Lupin enters into partnership with Acceliant

26 Feb 2015 Evaluate

Pharma major, Lupin has entered into a partnership with Acceliant, a global technology provider of advanced clinical trial data management solutions. Under this partnership, Lupin would leverage Acceliant's clinical trial platform for its clinical research and trials across Lupin Research programs.

Acceliant platforms ensure smooth execution of clinical data management activities such as database design, UAT and various report formats for business intelligence. It gives a client partner like Lupin a collaborative environment that brings global research teams to work within a single shared environment. 

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.

Lupin Share Price

2131.80 10.15 (0.48%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×